These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 32662879

  • 1. Media supplementation for targeted manipulation of monoclonal antibody galactosylation and fucosylation.
    Wells E, Song L, Greer M, Luo Y, Kurian V, Ogunnaike B, Robinson AS.
    Biotechnol Bioeng; 2020 Nov; 117(11):3310-3321. PubMed ID: 32662879
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Engineering nucleotide sugar synthesis pathways for independent and simultaneous modulation of N-glycan galactosylation and fucosylation in CHO cells.
    Prabhu A, Shanmugam D, Gadgil M.
    Metab Eng; 2022 Nov; 74():61-71. PubMed ID: 36152932
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.
    Fan Y, Jimenez Del Val I, Müller C, Wagtberg Sen J, Rasmussen SK, Kontoravdi C, Weilguny D, Andersen MR.
    Biotechnol Bioeng; 2015 Mar; 112(3):521-35. PubMed ID: 25220616
    [Abstract] [Full Text] [Related]

  • 6. CHO cell line specific prediction and control of recombinant monoclonal antibody N-glycosylation.
    Grainger RK, James DC.
    Biotechnol Bioeng; 2013 Nov; 110(11):2970-83. PubMed ID: 23737295
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification of manipulated variables for a glycosylation control strategy.
    St Amand MM, Radhakrishnan D, Robinson AS, Ogunnaike BA.
    Biotechnol Bioeng; 2014 Oct; 111(10):1957-70. PubMed ID: 24728980
    [Abstract] [Full Text] [Related]

  • 10. Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose.
    Gramer MJ, Eckblad JJ, Donahue R, Brown J, Shultz C, Vickerman K, Priem P, van den Bremer ET, Gerritsen J, van Berkel PH.
    Biotechnol Bioeng; 2011 Jul; 108(7):1591-602. PubMed ID: 21328321
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Supplementing glycosylation: A review of applying nucleotide-sugar precursors to growth medium to affect therapeutic recombinant protein glycoform distributions.
    Blondeel EJM, Aucoin MG.
    Biotechnol Adv; 2018 Jul; 36(5):1505-1523. PubMed ID: 29913209
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nickel and cobalt affect galactosylation of recombinant IgG expressed in CHO cells.
    Prabhu A, Gadgil M.
    Biometals; 2019 Feb; 32(1):11-19. PubMed ID: 30327978
    [Abstract] [Full Text] [Related]

  • 16. Valeric acid induces cell cycle arrest at G1 phase in CHO cell cultures and improves recombinant antibody productivity.
    Park JH, Noh SM, Woo JR, Kim JW, Lee GM.
    Biotechnol J; 2016 Mar; 11(4):487-96. PubMed ID: 26663903
    [Abstract] [Full Text] [Related]

  • 17. Interaction of cell culture process parameters for modulating mAb afucosylation.
    Nguyen Dang A, Mun M, Rose CM, Ahyow P, Meier A, Sandoval W, Yuk IH.
    Biotechnol Bioeng; 2019 Apr; 116(4):831-845. PubMed ID: 30597531
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. An efficient method to control high mannose and core fucose levels in glycosylated antibody production using deoxymannojirimycin.
    Shalel Levanon S, Aharonovitz O, Maor-Shoshani A, Abraham G, Kenett D, Aloni Y.
    J Biotechnol; 2018 Jun 20; 276-277():54-62. PubMed ID: 29673624
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.